Z4. COVID-19 Treatment
Poster Session: COVID-2019 and Co-Infections
Sean Avedissian, PharmD., MSc., PhD. (he/him/his)
Associate Professor
University of Nebraska Medical Center
Omaha, NE, United States
Ukamaka O. Modebelu, MS (she/her/hers)
Graduate Research Assistant
UNMC
Omaha, NE, United States
Nathaniel J. Rhodes, PharmD MS
Associate Professor
Midwestern University
Downers Grove, IL, United States
Kara W. Chew, M.D., M.S.
Associate Professor
David Geffen School of Medicine at University of California
Los Angeles, California, United States
.jpg "Eric S. Daar, MD photo")
Eric S. Daar, MD
Chief, Division of HIV Medicine
Lundquist Institute at Harbor-UCLA Medical Center
Torrance, CA, United States
David A. Wohl, M.D.
Professor
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina, United States
Joseph Eron, MD
Professor of Medicine
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina, United States
Simon Portsmouth, MD
Senior Medical Director
Shionogi Inc
Florham Park, NJ, United States
Takeki Uehara, Ph.D.
SHIONOGI & CO., LTD.
Osaka-shi, Osaka, Japan
Ryosuke Shimizu
Manager
Clinical Pharmacology & Pharmacokinetics, Project Management Department, Shionogi & Co., Ltd. Osaka, Japan
Osaka, Osaka, Japan
David Smith, MD, MAS
Professor of Medicine
University of California, San Diego
San Diego, California, United States
Judith S. Currier, MD, MSc (she/her/hers)
Professor of Medicine/ Executive Vice Chair for Research
David Geffen School of Medicine at University of California
Los Angeles, CA, United States
Annie Luetkemeyer, MD (she/her/hers)
Professor of Medicine
University of California San Francisco
San Francisco, CA, United States
Courtney Fletcher, Pharm.D.
University of Nebraska
Omaha, Nebraska, United States